Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner

Virology Journal

Zhong-tian Qi¹  Ping Zhao¹  Hao Ren¹  Zhao-ling Qin¹  Ting-ting Gao¹ 

[1] Department of Microbiology, Shanghai Key Laboratory of Medical Biodefense, Second Military Medical University, Shanghai 200433, China

关键词: PTEN;    pIRS-1 Ser307;    IRS-1;    Insulin resistance;    Hepatitis C virus;   

Others  :  1131023
DOI  :  10.1186/s12985-015-0241-4

 received in 2014-09-25, accepted in 2015-01-15,  发布年份 2015

【 摘 要 】

Background

Hepatitis C virus (HCV) infection was recently recognized as an independent risk factor for insulin resistance (IR), the onset phase of type 2 diabetes mellitus (T2DM). Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) negatively regulates PI3K/Akt signaling pathway, which is critical for IR development and progression of cirrhosis to hepatocellular carcinoma (HCC). Here, we investigate the role of PTEN in HCV-associated IR and explored the mechanisms by which HCV regulates PTEN.

Methods

Western blotting was used to detect the levels of insulin signaling pathway components, including insulin receptor substrate-1 (IRS-1), phosphorylated IRS-1 (pIRS-1) at serine 307 (Ser307), both phosphorylated Akt (pAkt) and total Akt. A time-course experiment measuring activation of the insulin signaling pathway was performed to assess the effect of HCV infection on insulin sensitivity by examining the phosphorylation levels of Akt and GSK3β, a downstream target of Akt. Huh7.5.1 cells were transduced with a lentiviral vector expressing PTEN or PTEN shRNA, and IRS-1 and pIRS-1 (Ser307) levels were determined in both HCV-infected and uninfected cells. The pc-JFH1-core plasmid was constructed to explore the underlying mechanisms by which HCV regulated PTEN and therefore IRS-1 levels.

Results

HCV infection inhibited the insulin signaling pathway by reducing the levels of IRS-1 and pAkt/Akt while increasing phosphorylation of IRS-1 Ser307. In addition, HCV infection decreased the sensitivity to insulin-induced stimulation by inhibiting Akt and GSK3β phosphorylation. Furthermore, PTEN mRNA and protein levels were reduced upon HCV infection as well as transfection with the pc-JFH1-core plasmid. The reduction in IRS-1 level observed in HCV-infected cells was rescued to a limited extent by overexpression of PTEN, which in turn slightly reduced pIRS-1 (Ser307) level. In contrast, IRS-1 level were significantly decreased and phosphorylation of IRS-1 at Ser-307 was strongly enhanced by PTEN knockdown, suggesting that both reduction in IRS-1 level and increase in IRS-1 phosphorylation at Ser307 upon HCV infection occurred in a PTEN-dependent manner.

Conclusions

HCV infection suppresses the insulin signaling pathway and promotes IR by repressing PTEN, subsequently leading to decreased levels of IRS-1 and increased levels of pIRS-1 at Ser307. The findings provide new insight on the mechanism of HCV-associated IR.

【 授权许可】

   
2015 Gao et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Bialek SR, Terrault NA: The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006, 10:697-715.
• [2]García-Monzón C, Lo Iacono O, Mayoral R, González-Rodríguez A, Miquilena-Colina ME, Lozano-Rodríguez T, et al.: Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. J Hepatol 2011, 54(1):142-52.
• [3]Vespasiani-Gentilucci U, Gallo P, De Vincentis A, Galati G, Picardi A: Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis. World J Gastroenterol 2014, 20(11):2825-38.
• [4]Bose SK, Ray R: Hepatitis C virus infection and insulin resistance. World J Diabetes 2014, 5(1):52-8.
• [5]Antonelli A, Ferrari SM, Giuggioli D, Di Domenicantonio A, Ruffilli I, Corrado A, et al.: Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes 2014, 5(5):586-600.
• [6]Mangia A, Ripoli M: Insulin resistance, steatosis and hepatitis C virus. Hepatol Int 2013, 7(Suppl 2):S782-9.
• [7]Chan CH, Hansen RD, Gilliver RS, Jones BE: Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance. Intern Med J 2013, 43(6):656-62.
• [8]Huang JF, Yu ML, Dai CY, Chuang WL: Glucose abnormalities in hepatitis C virus infection. Kaohsiung J Med Sci 2013, 29:61-8.
• [9]Banerjee S, Saito K, Ait-Goughoulte M, Meyer K, Ray RB, Ray R: Hepatitis C virus core protein upregulates serin phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance. J Virol 2008, 82:2606-12.
• [10]Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, et al.: Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004, 165:1499-508.
• [11]Lecube A, Hernández C, Genescà J, Simó R: Proinflammatory cytokines, insulin resistance and insulin secretion in chronic hepatitis C patients: a case–control study. Diabetes Care 2006, 29:1096-101.
• [12]Peyrou M, Bourgoin L, Foti M: PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer. Dig Dis 2010, 28:236-46.
• [13]Vinciguerra M, Foti M: PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signaling. Arch Physiol Biochem 2006, 112(2):89-104.
• [14]Vinciguerra M, Veyrat-Durebex C, Moukil MA, Rubbia-Brandt L, Rohner-Jeanrenaud F, Foti M: PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism. Gastroenterology 2008, 134:268-80.
• [15]Lee J, Kim MS: The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res Clin Pract 2007, 77:49-57.
• [16]Shi Y, Wang J, Chandarlapaty S, Cross J, Thompson C, Rosen N, et al.: PTEN is a protein tyrosine phosphatase for IRS1. Nat Struct Mol Biol 2014, 21:522-7.
• [17]Bugianesi E, Mccullough AJ, Marchesini G: Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005, 42:987-1000.
• [18]Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N: Impaired IRS-1/PI3-kinase signalling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003, 38:1384-92.
• [19]Kondapaka SB, Zarnowski M, Yver DR, Sausville EA, Cushman SW: 7-hydroxystaurosporine (UCN-01) inhibition of Akt Thr308 but not Ser473 phosphorylation: a basis for decreased insulin-stimulated glucose transport. Clin Cancer Res 2004, 10:7192-8.
• [20]Stagakis I, Bertsias G, Karvounaris S, Kavousanaki M, Virla D, Raptopoulou A, et al.: Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance. Arthritis Res Ther 2012, 14(3):R141. BioMed Central Full Text
• [21]Pazienza V, Clément S, Pugnale P, Conzelman S, Foti M, Mangia A, et al.: The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 2007, 45:1164-71.
• [22]Kasai D, Adachi T, Deng L, Nagano-Fujii M, Sada K, Ikeda M, et al.: HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J Hepatol 2009, 50:883-94.
• [23]Bose SK, Shrivastava S, Meyer K, Ray RB, Ray R: Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. J Virol 2012, 86:6315-22.
• [24]Fritsche L, Weigert C, Häring H-U, Lehmann R: How insulin receptor substrate proteins regulate the metabolic capacity of the liver-implications for health and disease. Curr Med Chem 2008, 15:1316-29.
• [25]Parvaiz F, Manzoor S, Iqbal J, McRae S, Javed F, Ahmed QL, et al.: Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: a metabolic syndrome. Arch Virol 2014, 159(5):1017-25.
• [26]del Campo JA, García-Valdecasas M, Rojas L, Rojas Á, Romero-Gómez M: The hepaitits C virus modulates insulin signaling pathway in vitro promoting insulin resistance. PLoS One 2012, 7:e47904.
• [27]Clément S, Peyrou M, Sanchez-Pareja A, Bourgoin L, Ramadori P, Suter D, et al.: Down-Regulation of Phosphatase and Tensin Homolog by Hepatitis C Virus Core 3a in Hepatocytes Triggers the Formation of Large Lipid Droplets. Hepatology 2011, 54(1):38-49.
• [28]Vinciguerra M, Foti M: PTEN at the crossroad of metabolic diseases and cancer in the liver. Ann Hepatol 2008, 7(3):192-9.
• [29]Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-58.
• [30]Vasudevan KM, Gurumurthy S, Rangnekar VM: Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol 2004, 24:1007-21.
• [31]Serfaty L, Forns X, Goeser T, Ferenci P, Nevens F, Carosi G, et al.: Insulin resistance and response to telaprevir plus peginterferon alfa and ribavirin in treatment-naive, genotype 1 HCV patients. Gut 2012, 61:1473-80.